Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.39% | -10.97% | -10.20% | -19.92% | -26.98% |
| Total Depreciation and Amortization | 10.38% | -0.47% | 8.40% | 16.96% | -5.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.34% | 8.82% | 33.82% | 39.10% | 17.24% |
| Change in Net Operating Assets | -0.83% | 9,448.39% | 99.25% | -731.50% | 19.34% |
| Cash from Operations | -13.77% | 2.24% | 13.34% | -45.84% | -30.50% |
| Capital Expenditure | -48.62% | 67.14% | 5.17% | -338.92% | -184.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -48.98% | -- | -- | -- |
| Cash from Investing | -1.00% | -48.39% | 3,022.41% | -171.48% | 1,847.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,321.13% | -81.27% | -94.47% | -92.63% | 94,847.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,057.75% | -81.27% | -94.47% | -92.63% | 94,847.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.98% | -341.11% | 118.50% | -123.08% | 718.38% |